Latest Articles

  • In reply: Is diabetes still a compelling indication for renin-angiotensin-aldosterone system inhibitors?
    Sunil Bhandari, MBChB, FRCP, PhD, M Clin Edu, FHEA, Tasnim Momoniat, MBChB, MRCP (UK) and Duha Ilyas, MBBS, MRCP (UK)
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 9-10; DOI: https://doi.org/10.3949/ccjm.87c.01002
  • Sepsis and septic shock: Guideline-based management
    Siddharth Dugar, MD, Chirag Choudhary, MD, MBA and Abhijit Duggal, MD, MPH, MSc, FACP
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 53-64; DOI: https://doi.org/10.3949/ccjm.87a.18143

    Sepsis requires prompt recognition, appropriate antibiotics, careful hemodynamic support, and control of the source of infection.

  • Is diabetes still a compelling indication for renin-angiotensin-aldosterone system inhibitors?
    Robert Fakheri, MD, Sripal Bangalore, MD and Franz Messerli, MD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 9; DOI: https://doi.org/10.3949/ccjm.87c.01001
  • How should diabetic dyslipidemia be treated?
    Taher Modarressi, MD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 11; DOI: https://doi.org/10.3949/ccjm.87c.01003
  • Giant uric acid stone in the bladder
    Alexander E. Sullivan, MD and Suchita Shah Sata, MD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 14-15; DOI: https://doi.org/10.3949/ccjm.87a.19069

    The patient said he had to urinate 30 to 40 times a day, but only in small amounts.

  • Gene therapy in sickle cell disease: Possible utility and impact
    Susanna A. Curtis, MD, MS and Niketa C. Shah, MD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 28-29; DOI: https://doi.org/10.3949/ccjm.87a.19124

    CRISPR-Cas9 makes it possible to edit the patient’s own genes, but questions remain.

  • Off-label and oft-prescribed
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine December 2019, 86 (12) 766-767; DOI: https://doi.org/10.3949/ccjm.86b.12019

    When prescribing drugs for uses beyond their FDA indications, we need to explain their anticipated side effects and benefits.

  • How to respond to flu vaccine doubters
    Sherif Beniameen Mossad, MD, FACP, FIDSA, FAST
    Cleveland Clinic Journal of Medicine December 2019, 86 (12) 782-788; DOI: https://doi.org/10.3949/ccjm.86a.19139

    Misinformation and unfounded fears abound. What should you tell patients who say no to a fl u shot?

  • Beyond depression: Other uses for tricyclic antidepressants
    Joanne Schneider, DNP, RN, CNP, Mary Patterson, CNP and Xavier F. Jimenez, MD, MA
    Cleveland Clinic Journal of Medicine December 2019, 86 (12) 807-814; DOI: https://doi.org/10.3949/ccjm.86a.19005

    The pharmacology of these drugs, their potential uses in conditions other than depression, and safety considerations.

  • Gabapentin for alcohol use disorder: A good option, or cause for concern?
    Vania Modesto-Lowe, MD, MPH, Gregory C. Barron, MD, Benjamin Aronow, BS and Margaret Chaplin, MD
    Cleveland Clinic Journal of Medicine December 2019, 86 (12) 815-823; DOI: https://doi.org/10.3949/ccjm.86a.18128

    There is concern about the potential for abuse. Use it only as a second-line alternative, with caution.

Pages